Scott Michael Habig, Chief Commercial Officer at Aurinia Pharmaceuticals Inc. (AUPH), sold 35,554 shares at $5.60 ($199K) on 2024-03-06, disclosed to the SEC on 2024-03-07.
Open-market sale of $199k AUPH by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.60 | 17,777 | $100K | 50.0% |
| 2 | $5.60 | 17,777 | $100K | 50.0% |
| Total | $5.60 avg | 35,554 | $199K | 100% |
| Filing → |
| AUPH | BUY | 2022-11-14 | $25K | — | Filing → |